Physician profile
Binna Lee
NPI 1083496368
$658.99
in general payments reported to CMS, 2019-2025
15 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $355 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.99 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $139.45 | 2024 | Jakafi, Monjuvi |
| Novartis Pharmaceuticals Corporation | $109.04 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $88.19 | 2024-2025 | Verquvo, Keytruda, Welireg |
| Lilly USA, LLC | $50.32 | 2024-2025 | Jaypirca, Verzenio, Zepbound |
| Genzyme Corporation | $30.63 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $29.98 | 2025 | Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.46 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $27.03 | 2025 | |
| Boston Scientific Corporation | $26.96 | 2025 | Watchman Flx |
| Pharmaessentia USA Corporation | $26.81 | 2024 | Besremi |
| Inspire Medical Systems, INC. | $21.43 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $21.25 | 2025 | Opsynvi |
| Xeris Pharmaceuticals, INC. | $20.67 | 2025 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $19.81 | 2024 | Thinprep 2000 Processor |
| Sun Pharmaceutical Industries INC. | $18.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binna Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.